ILD is common among rheumatologic diseases, and is associated with significant morbidity and mortality1,3 Histologic presentation of autoimmune ILD is variable, ranging from inflammatory to fibrotic1 Clinical manifestations of autoimmune ILD also vary greatly, ranging from clinically insignificant or mild...
Interstitial lung disease (ILD) is an increasingly recognised complication in connective tissue diseases (CTD). Early detection of progressive ILD amongst patients with CTD is essential for administration of treatment in a timely manner. We aim to determine if domiciliary smartphone app-based spirometer...
In regards to efficacy, it stabilized disease progression even in non IPF fibrosis, particularly in CTD-ILD. Importantly, nintedanib did not appear to have excess adverse effects when taken in combination with other immunosuppressants, supporting its role as an add-on treatment in those patients....